Back to GA Gotham Asset Management, LLC

CORTCORT

Showing 8 of 31 quarters

Position history for GAGotham Asset Management, LLC's holdings in Corcept Therapeutics Incorporated.

Yes. Gotham Asset Management holds 60,181 shares of CORT (Corcept Therapeutics), worth $5.2M, as of its Q2 2026 13F filing. It increased the position from 17,918 shares in Q1 2026. Gotham Asset Management has held CORT in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$5.2M

Current Shares

60,181

Total Value Change

+$4.4M

Total Shares Change

+41,567

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
60,181
+235.9%
$5.2M0.0%$86.95
44
2026-Q1
Increased
17,918
+3.3%
$722,2750.0%$40.31
25
2025-Q4
Decreased
17,352
-0.1%
$603,8500.0%$34.80
0
2025-Q3
Increased
17,362
+0.3%
$1.4M0.0%$83.11
25
2025-Q2
Decreased
17,312
-0.6%
$1.3M0.0%$73.40
0
2025-Q1
Decreased
17,423
-9.0%
$2M0.0%$114.22
0
2024-Q4
Increased
19,137
+2.8%
$964,3130.0%$50.39
26
2024-Q3
Decreased
18,614
-25.4%
$861,4560.0%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used